Holocene Advisors Portfolio holdings
AUM
$40.6B
This Quarter Return
+13.4%
1 Year Return
+31.17%
3 Year Return
+129.55%
5 Year Return
+263.78%
10 Year Return
–
AUM
$27.1B
AUM Growth
+$27.1B
(+6%)
Cap. Flow
-$675M
Cap. Flow
% of AUM
-2.49%
Top 10 Holdings %
Top 10 Hldgs %
14.45%
Holding
906
New
227
Increased
268
Reduced
192
Closed
215
Top Buys
| 1 |
Microsoft
MSFT
|
$416M |
| 2 |
Broadcom
AVGO
|
$274M |
| 3 |
Edwards Lifesciences
EW
|
$241M |
| 4 |
Elevance Health
ELV
|
$220M |
| 5 |
GE Aerospace
GE
|
$219M |
Top Sells
| 1 |
Booking.com
BKNG
|
$354M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$268M |
| 3 |
American Express
AXP
|
$263M |
| 4 |
Dollar General
DG
|
$257M |
| 5 |
Linde
LIN
|
$196M |
Sector Composition
| 1 | Healthcare | 21.86% |
| 2 | Consumer Discretionary | 15.79% |
| 3 | Technology | 15.23% |
| 4 | Consumer Staples | 12.17% |
| 5 | Industrials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Shake Shack
SHAK
$4.23B
| $68.7M | 0.25% |
660,139
+42,188
| +7% | +$4.39M |
|
127
Permian Resources
PR
$9.73B
| $68.4M | 0.25% |
3,870,763
+526,148
| +16% | +$9.29M |
|
|
BPMC
128
DELISTED
Blueprint Medicines
BPMC
| $67.9M | 0.25% |
+715,303
| New | +$67.9M |
|
129
McKesson
MCK
$85.9B
| $66.9M | 0.25% |
124,708
-32,845
| -21% | -$17.6M |
|
130
Natera
NTRA
$23B
| $65M | 0.24% |
710,232
-365,042
| -34% | -$33.4M |
|
131
Nasdaq
NDAQ
$53.8B
| $64.9M | 0.24% |
+1,028,765
| New | +$64.9M |
|
132
Synopsys
SNPS
$110B
| $64.5M | 0.24% |
112,787
+77,444
| +219% | +$44.3M |
|
133
Moody's
MCO
$89B
| $64.3M | 0.24% |
+163,569
| New | +$64.3M |
|
134
Celanese
CE
$4.89B
| $63.4M | 0.23% |
+368,854
| New | +$63.4M |
|
135
Repligen
RGEN
$6.54B
| $63M | 0.23% |
342,388
+37,474
| +12% | +$6.89M |
|
|
ITCI
136
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $62.9M | 0.23% |
909,090
-352,767
| -28% | -$24.4M |
|
137
Mastercard
MA
$536B
| $61.5M | 0.23% |
127,670
+88,708
| +228% | +$42.7M |
|
138
Raymond James Financial
RJF
$33.2B
| $57.8M | 0.21% |
450,222
+396,096
| +732% | +$50.9M |
|
139
Eli Lilly
LLY
$661B
| $57.8M | 0.21% |
74,303
-32,778
| -31% | -$25.5M |
|
140
Bank of America
BAC
$371B
| $56.7M | 0.21% |
+1,494,443
| New | +$56.7M |
|
141
CBRE Group
CBRE
$47.3B
| $55.4M | 0.2% |
569,284
-177,978
| -24% | -$17.3M |
|
142
Synchrony
SYF
$28.1B
| $54.7M | 0.2% |
1,268,500
+600,879
| +90% | +$25.9M |
|
143
Molina Healthcare
MOH
$9.6B
| $54.3M | 0.2% |
132,245
+22,997
| +21% | +$9.45M |
|
144
Vera Therapeutics
VERA
$1.47B
| $52.1M | 0.19% |
+1,207,380
| New | +$52.1M |
|
145
Kura Oncology
KURA
$732M
| $52M | 0.19% |
2,437,463
| – | – |
|
|
HCP
146
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $51.1M | 0.19% |
1,897,205
-1,832,095
| -49% | -$49.4M |
|
147
Cadence Design Systems
CDNS
$94.6B
| $50.6M | 0.19% |
162,697
-267,233
| -62% | -$83.2M |
|
148
NextEra Energy, Inc.
NEE
$148B
| $50M | 0.18% |
782,022
+646,358
| +476% | +$41.3M |
|
149
Roblox
RBLX
$92.5B
| $49.1M | 0.18% |
1,286,543
-1,052,428
| -45% | -$40.2M |
|
150
Encompass Health
EHC
$12.5B
| $48.3M | 0.18% |
585,374
-235,609
| -29% | -$19.5M |
|